Skip to search formSkip to main contentSkip to account menu

Remoxipride

Known as: (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide, Remoxipridum, Remoxipride [Chemical/Ingredient] 
An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
A number of potential neuroleptic drugs of the substituted benzamide type have been compared with some reference neuroleptic… 
Highly Cited
1990
Highly Cited
1990
Abstract Nine double‐blind studies comparing remoxipride to haloperidol in the treatment of acute schizophrenia formed the basis…